TS-1 (S-1)

DRUG2 trials

Sponsors

Taiho Pharmaceutical Co., Ltd., National Cancer Center, Korea

Conditions

Advanced Non-Small Cell Lung CancerGastric Cancer

Phase 1

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

National Cancer Center, KoreaAdvanced Non-Small Cell Lung Cancer

Start: 2008-10-31End: 2012-12-31Target: 74Updated: 2010-10-25

Phase 3

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

CompletedNCT00152217

Taiho Pharmaceutical Co., Ltd.Gastric Cancer

Start: 2001-09-30End: 2010-12-31Target: 1000Updated: 2011-07-07

Related Papers

Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.

2018-04-2029 citations

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

2007-11-011867 citations